跳到正文

Inhibrx Biosciences, Inc.(INBX)内部人交易:高管与董事近期交易

过去 18 个月,共有 12 位内部人为 Inhibrx Biosciences, Inc.(INBX)报告了 49 笔 Form 4 交易(最近一笔 2026-10-14)。

日期内部人职务类型股数市值
2026-10-14Lappe MarkChief Executive Officer买入2,470$207,655
2026-10-14Lappe MarkChief Executive Officer买入2,470$209,948
2026-10-14Lappe MarkChief Executive Officer买入100$8,576
2026-10-14Lappe MarkChief Executive Officer买入2,449$205,889
2026-10-14Lappe MarkChief Executive Officer买入2,451$208,333
2026-10-14Lappe MarkChief Executive Officer买入100$8,576
2026-09-28Lappe MarkChief Executive Officer买入3,000$305,100
2026-09-28Lappe MarkChief Executive Officer买入2,176$216,730
2026-09-28Lappe MarkChief Executive Officer买入1,500$148,320
2026-09-28Lappe MarkChief Executive Officer买入3,324$328,644
2026-09-23Kayyem Jon Faiz董事买入5,000$500,000
2026-09-17Kayyem Jon Faiz董事买入5,000$500,000
2026-09-15MANHARD KIMBERLY董事卖出500$55,130
2026-09-15MANHARD KIMBERLY董事卖出500$52,525
2026-09-15MANHARD KIMBERLY董事卖出500$55,890
2026-09-10MANHARD KIMBERLY董事卖出500$57,570
2026-09-10MANHARD KIMBERLY董事卖出500$57,900
2026-09-08Lappe MarkChief Executive Officer买入9,681$1.1M
2026-09-08Kayyem Jon Faiz董事买入5,000$567,600
2026-09-08FORSYTH DOUGLAS董事买入2,500$286,625
2026-09-08Lappe MarkChief Executive Officer买入5,895$585,315
2026-09-08Lappe MarkChief Executive Officer买入6,605$664,727
2026-09-08Lappe MarkChief Executive Officer买入1,100$117,832
2026-09-08Lappe MarkChief Executive Officer买入500$54,120
2026-09-08Lappe MarkChief Executive Officer买入1,219$136,382

来源:SEC Form 4 申报文件 · 截至 2026-10-14